These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7687554)

  • 1. Objective and subjective response criteria to diagnose benign prostatic hyperplasia.
    Roehrborn CG
    Eur Urol; 1993; 24 Suppl 1():2-11. PubMed ID: 7687554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptoms and quality of life versus age, prostate volume, and urodynamic parameters in 565 strictly selected men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Eckhardt MD; van Venrooij GE; Boon TA
    Urology; 2001 Apr; 57(4):695-700. PubMed ID: 11306383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic enlargement, symptomatology and pressure/flow evaluation: interrelations in patients with symptomatic BPH.
    Poulsen AL; Schou J; Puggaard L; Torp-Pedersen S; Nordling J
    Scand J Urol Nephrol Suppl; 1994; 157():67-73. PubMed ID: 7524143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urodynamics in benign prostatic hyperplasia (BPH).
    Schäfer W
    Arch Ital Urol Androl; 1993 Dec; 65(6):599-613. PubMed ID: 7508790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multichannel urodynamic studies in men with benign prostatic hyperplasia. Indications and interpretation.
    Blaivas JG
    Urol Clin North Am; 1990 Aug; 17(3):543-52. PubMed ID: 1695781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The value of symptom score, quality of life score, maximal urinary flow rate, residual volume and prostate size for the diagnosis of obstructive benign prostatic hyperplasia: a urodynamic analysis.
    van Venrooij GE; Boon TA
    J Urol; 1996 Jun; 155(6):2014-8. PubMed ID: 8618311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The urodynamic examination in prostatism].
    Svihra J; Poulsen AL; Schou J
    Rozhl Chir; 1993 Oct; 72(7):307-10. PubMed ID: 7508146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of functional examination techniques for the assessment of the clinical aspects of benign prostatic hyperplasia].
    Hohenfellner M; Thüroff JW
    Urologe A; 1992 May; 31(3):142-9. PubMed ID: 1377431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of high bladder neck elevation with urodynamic bladder outlet obstruction in patients with lower urinary tract symptoms and benign prostatic hyperplasia.
    Kang M; Kim M; Choo MS; Bae J; Ku JH; Yoo C; Oh SJ
    Urology; 2014 Dec; 84(6):1461-6. PubMed ID: 25432841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of life and clinical symptom improvement support prostatic artery embolization for patients with acute urinary retention caused by benign prostatic hyperplasia.
    Carnevale FC; da Motta-Leal-Filho JM; Antunes AA; Baroni RH; Marcelino AS; Cerri LM; Yoshinaga EM; Cerri GG; Srougi M
    J Vasc Interv Radiol; 2013 Apr; 24(4):535-42. PubMed ID: 23434084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between the International Prostatic Symptom Score and a pressure-flow study in the evaluation of symptomatic benign prostatic hyperplasia.
    Netto Júnior NR; D'Ancona CA; de Lima ML
    J Urol; 1996 Jan; 155(1):200-2. PubMed ID: 7490834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship of detrusor instability and symptoms with objective parameters used for diagnosing bladder outlet obstruction: a prospective study.
    Wadie BS; Ebrahim el-HE; Gomha MA
    J Urol; 2002 Jul; 168(1):132-4. PubMed ID: 12050506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between lower urinary tract symptoms and urethral function in benign prostatic hyperplasia.
    Kaplan SA
    J Urol; 2005 Sep; 174(3):1010-1. PubMed ID: 16094029
    [No Abstract]   [Full Text] [Related]  

  • 16. Symptomatology and diagnosis of benign prostatic hyperplasia.
    Pavone-Macaluso M
    Eur Urol; 1991; 20 Suppl 1():41-3. PubMed ID: 1722161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
    van Melick HH; van Venrooij GE; Eckhardt MD; Boon TA
    J Urol; 2003 Apr; 169(4):1411-6. PubMed ID: 12629374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of intravesical prostatic protrusion and resistive index is useful to predict bladder outlet obstruction in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
    Suzuki T; Otsuka A; Ozono S
    Int J Urol; 2016 Nov; 23(11):929-933. PubMed ID: 27545297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive patient evaluation for benign prostatic hyperplasia.
    Jepsen JV; Bruskewitz RC
    Urology; 1998 Apr; 51(4A Suppl):13-8. PubMed ID: 9586591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Latest trends and recommendations on epidemiology, diagnosis, and treatment of benign prostatic hyperplasia (BPH)].
    Gabuev A; Oelke M
    Aktuelle Urol; 2011 May; 42(3):167-78. PubMed ID: 21604233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.